| Literature DB >> 30993746 |
Kazuko Iwamoto1, Shinichi Matsumura2, Yuri Yoshioka2, Ayami Yamamoto1, Shohei Makino2, Tatsuya Moriyama1,3, Nobuhiro Zaima1,3.
Abstract
Accumulation of amyloid-β peptide is associated with Alzheimer's dementia. Previously, we reported that sesamin and sesamolin inhibited β-secretase activity in vitro, and each was transported to the serum and brain in mice after oral administration. However, the bioavailability of sesamin and sesamolin was poor in mice. In this study, we aimed to improve the bioavailability of sesamin and sesamolin. We found that the levels of sesamin and sesamolin in mouse serum and brain were higher after the administration of a mixture of sesame extract and turmeric oil (MST) than those after administering sesame extract alone. Serum sesamin and sesamolin contents in the MST-treated group were 23-fold and 15-fold higher, respectively, than those in the sesame extract-treated group. Brain sesamin and sesamolin contents in the MST-treated group were 14-fold and 11-fold higher, respectively, than those in the sesame extract-treated group. These results suggest that turmeric oil is an effective solvent to enhance the bioavailability of sesamin and sesamolin.Entities:
Keywords: LC-MS; Sesamin; Sesamolin; Turmeric oil; Turmerones
Year: 2019 PMID: 30993746 DOI: 10.1002/lipd.12147
Source DB: PubMed Journal: Lipids ISSN: 0024-4201 Impact factor: 1.880